FAM192A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.282000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.463400E-01
Normal-vs-Stage2
7.288300E-02
Normal-vs-Stage3
1.160780E-01
Normal-vs-Stage4
8.523000E-01
Stage1-vs-Stage2
4.956600E-01
Stage1-vs-Stage3
5.052600E-01
Stage1-vs-Stage4
1.733210E-01
Stage2-vs-Stage3
1.520020E-01
Stage2-vs-Stage4
1.015750E-01
Stage3-vs-Stage4
1.200190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.141800E-02
Normal-vs-AfricanAmerican
4.274400E-01
Normal-vs-Asian
9.918400E-02
Caucasian-vs-AfricanAmerican
5.735000E-01
Caucasian-vs-Asian
7.848000E-01
AfricanAmerican-vs-Asian
5.712800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.362200E-02
Normal-vs-Female
5.570300E-02
Male-vs-Female
7.016000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.166600E-01
Normal-vs-Age(41-60Yrs)
4.029200E-01
Normal-vs-Age(61-80Yrs)
9.126000E-02
Normal-vs-Age(81-100Yrs)
2.782200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.500570E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.954000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.599200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.608230E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.802000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.954400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.055700E-02
Normal-vs-Daily Drinker
1.251990E-01
Normal-vs-Weekly Drinker
7.564400E-02
Normal-vs-Occasional Drinker
1.792580E-01
Normal-vs-Social Drinker
1.179400E-01
Non Drinker-vs-Daily Drinker
9.247000E-01
Non Drinker-vs-Weekly Drinker
8.082000E-01
Non Drinker-vs-Occasional Drinker
1.309200E-01
Non Drinker-vs-Social Drinker
5.122000E-01
Daily Drinker-vs-Weekly Drinker
7.792600E-01
Daily Drinker-vs-Occasional Drinker
2.329800E-01
Daily Drinker-vs-Social Drinker
6.360800E-01
Weekly Drinker-vs-Occasional Drinker
1.216030E-01
Weekly Drinker-vs-Social Drinker
4.266200E-01
Occasional Drinker-vs-Social Drinker
4.450200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.982200E-01
Normal-vs-Grade 2
5.042800E-01
Normal-vs-Grade 3
4.714300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.638870E-03
Grade 1-vs-Grade 3
4.320900E-03
Grade 1-vs-Grade 4
2.982200E-01
Grade 2-vs-Grade 3
5.254200E-01
Grade 2-vs-Grade 4
5.042800E-01
Grade 3-vs-Grade 4
4.714300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.244400E-02
Normal-vs-NonDiabetic
6.002400E-02
Diabetic-vs-NonDiabetic
3.556200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.759200E-01
Normal-vs-NoPancreatitis
3.944100E-02
Pancreatitis-vs-NoPancreatitis
1.545850E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.134360E-01
Normal-vs-N1
6.142000E-02
N0-vs-N1
3.256400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.156800E-01
Normal-vs-TP53-NonMutant
3.193900E-02
TP53-Mutant-vs-TP53-NonMutant
2.71949999963716E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
